Clinical Trials on Plasmodium Vivax Malaria in Ireland

Total 8 results

Lihir Medical Centre

Withdrawn

Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly (LiHMS)

Malaria | Anaemia | Hyper-reactive Malarial Splenomegaly

Papua New Guinea
University of Oxford

Completed

Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS

Malaria

Ireland
Novartis Pharmaceuticals
Medicines for Malaria Venture

Completed

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz

Malaria

United Kingdom
Novartis Pharmaceuticals
Medicines for Malaria Venture

Completed

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir

Malaria

United Kingdom
Novartis Pharmaceuticals
Medicines for Malaria Venture

Completed

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazole

Malaria

United Kingdom
London School of Hygiene and Tropical Medicine
Universitas Sumatera Utara

Completed

Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia

Malaria, Falciparum

Indonesia
Lihir Medical Centre
Barcelona Institute for Global Health; Papua New Guinea Institute of Medical... and other collaborators

Completed

Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns (ECG-Lihir)

Malaria

Papua New Guinea
Sanaria Inc.
Swiss Tropical & Public Health Institute; Ifakara Health Institute; Government... and other collaborators

Completed

Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea

Malaria

Equatorial Guinea

Clinical Trials on Plasmodium Vivax Malaria in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations